The HRAS1 minisatellite locus increases the risk of ovarian cancer in BRCA1 carriers, but not in BRCA2 carriers or sporadic ovarian cancer.

被引：0
|
作者：
Chu, W
McLaughlin, J
Phelan, C
Cole, D
Risch, H
Narod, S
机构：
[1] Sunnybrook & Womens Coll Hlth Sci Ctr, Ctr Res Womens Hlth, Toronto, ON, Canada
[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Div Epidemiol & Stat, Toronto, ON M5G 1X5, Canada
[3] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[4] Banting Inst, Dept Lab Med & Pathobiol, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
381
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [2] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    [J]. HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [3] Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus
    Phelan, CM
    Rebbeck, TR
    Weber, BL
    Devilee, P
    Ruttledge, MH
    Lynch, HT
    Lenoir, GM
    Stratton, MR
    Easton, DF
    Ponder, BAJ
    CannonAlbright, L
    Larsson, C
    Goldgar, DE
    Narod, SA
    [J]. NATURE GENETICS, 1996, 12 (03) : 309 - 311
  • [4] Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Gasowska-Bodnar, Agnieszka
    Szczylik, Cezary
    [J]. GINEKOLOGIA POLSKA, 2014, 85 (05) : 377 - 381
  • [5] Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
    Xia, Yue Yin
    Lubinski, Jan
    Rosen, Barry
    Moller, Pal
    Eisen, Andrea
    Ainsworth, Peter
    Senter, Leigha
    Neuhausen, Susan
    Singer, Christian
    Brooks, Jennifer
    Sun, Ping
    Narod, Steven
    Kotsopoulos, Joanne
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S50 - S51
  • [6] Weight gain and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kim, Shana
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William
    Singer, Christian
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan
    Olopade, Olufunmilayo
    Eng, Charis
    Weitzel, Jeffrey
    Fruscio, Robert
    Narod, Steven
    Kotsopoulos, Joanne
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S357 - S358
  • [7] Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    Satagopan, JM
    Boyd, J
    Kauff, ND
    Robson, M
    Scheuer, L
    Narod, S
    Offit, K
    [J]. CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3776 - 3781
  • [8] Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kim, Shana J.
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth Y.
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William D.
    Singer, Christian F.
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan L.
    Olopade, Olufunmilayo, I
    Eng, Charis
    Weitzel, Jeffrey N.
    Fruscio, Robert
    Narod, Steven A.
    Kotsopoulos, Joanne
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2038 - 2043
  • [9] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [10] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    [J]. Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
12345